STOCK TITAN

Insider plans 11,208-share Rule 144 sale in KURA (NASDAQ: KURA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of KURA filed a notice of intent to sell up to 11,208 shares of common stock on or about 01/27/2026 through Morgan Stanley Smith Barney LLC on the NASDAQ market, with an aggregate market value of $94,931.76.

The shares relate to restricted stock units that vested on 01/27/2026 in three blocks of 4,096, 2,335, and 4,777 shares acquired from the issuer. The filing notes that there were 88,309,441 shares of this class outstanding and includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the KURA Form 144 filing disclose about planned share sales?

The Form 144 shows a KURA shareholder intends to sell up to 11,208 shares of common stock. The estimated aggregate market value is $94,931.76, and the planned sale is through Morgan Stanley Smith Barney LLC on the NASDAQ market.

How many KURA shares are outstanding compared with the Form 144 sale?

The filing states there are 88,309,441 shares of the relevant KURA class outstanding. The planned sale of 11,208 shares is a small fraction of this baseline figure, providing context for the relative size of the proposed transaction.

How were the KURA shares in the Form 144 acquired by the seller?

The shares come from vested restricted stock units (RSUs) acquired from the issuer on 01/27/2026. Three RSU transactions are listed: 4,096, 2,335, and 4,777 shares, all with the same acquisition and payment date.

When is the KURA Form 144 sale expected to occur and on which exchange?

The filing lists an approximate date of sale of 01/27/2026. The common stock is expected to be sold on the NASDAQ exchange, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the transaction.

What representation does the seller make in the KURA Form 144 notice?

The seller represents that they do not know any material adverse information about KURA’s current or prospective operations that has not been publicly disclosed, a standard affirmation included in connection with planned sales under Rule 144.
Kura Oncology Inc

NASDAQ:KURA

KURA Rankings

KURA Latest News

KURA Latest SEC Filings

KURA Stock Data

723.12M
87.02M
Biotechnology
Pharmaceutical Preparations
Link
United States
SAN DIEGO